Eastbourne Capital Management Llc/ca - Net Worth and Insider Trading

Eastbourne Capital Management Llc/ca Net Worth

The estimated net worth of Eastbourne Capital Management Llc/ca is at least $399 Million dollars as of 2024-09-20. Eastbourne Capital Management Llc/ca is the 10% Owner of MGIC Investment Corp and owns about 10,299,755 shares of MGIC Investment Corp (MTG) stock worth over $265 Million. Eastbourne Capital Management Llc/ca is the 10% Owner of Sarepta Therapeutics Inc and owns about 943,204 shares of Sarepta Therapeutics Inc (SRPT) stock worth over $120 Million. Eastbourne Capital Management Llc/ca is also the 10% Owner of Cassava Sciences Inc and owns about 461,457 shares of Cassava Sciences Inc (SAVA) stock worth over $14 Million. Besides these, Eastbourne Capital Management Llc/ca also holds MabVax Therapeutics Holdings Inc (MBVXQ) . Details can be seen in Eastbourne Capital Management Llc/ca's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Eastbourne Capital Management Llc/ca has not made any transactions after 2010-03-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Eastbourne Capital Management Llc/ca

Eastbourne Capital Management Llc/ca Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Eastbourne Capital Management Llc/ca owns 4 companies in total, including MabVax Therapeutics Holdings Inc (MBVXQ) , Sarepta Therapeutics Inc (SRPT) , and Cassava Sciences Inc (SAVA) among others .

Click here to see the complete history of Eastbourne Capital Management Llc/ca’s form 4 insider trades.

Insider Ownership Summary of Eastbourne Capital Management Llc/ca

Ticker	Comapny	Transaction Date	Type of Owner
MBVXQ	MabVax Therapeutics Holdings Inc	2010-05-10	10 percent owner
SRPT	Sarepta Therapeutics Inc	2010-03-04	10 percent owner
SAVA	Cassava Sciences Inc	2009-09-29	10 percent owner
		2009-09-16	10 percent owner

Eastbourne Capital Management Llc/ca Latest Holdings Summary

Eastbourne Capital Management Llc/ca currently owns a total of 4 stocks. Among these stocks, Eastbourne Capital Management Llc/ca owns 10,299,755 shares of MGIC Investment Corp (MTG) as of September 16, 2009, with a value of $265 Million and a weighting of 66.42%. Eastbourne Capital Management Llc/ca owns 943,204 shares of Sarepta Therapeutics Inc (SRPT) as of March 4, 2010, with a value of $120 Million and a weighting of 30.07%. Eastbourne Capital Management Llc/ca also owns 461,457 shares of Cassava Sciences Inc (SAVA) as of September 29, 2009, with a value of $14 Million and a weighting of 3.51%. The other 1 stocks MabVax Therapeutics Holdings Inc (MBVXQ) have a combined weighting of 0% among all his current holdings.

Latest Holdings of Eastbourne Capital Management Llc/ca

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
MTG	MGIC Investment Corp	2009-09-16	10,299,755	25.71	264,806,701
SRPT	Sarepta Therapeutics Inc	2010-03-04	943,204	127.10	119,881,228
SAVA	Cassava Sciences Inc	2009-09-29	461,457	30.36	14,009,835
MBVXQ	MabVax Therapeutics Holdings Inc	2009-09-30	2,224	0.02	51

Holding Weightings of Eastbourne Capital Management Llc/ca

Eastbourne Capital Management Llc/ca Form 4 Trading Tracker

According to the SEC Form 4 filings, Eastbourne Capital Management Llc/ca has made a total of 0 transactions in MGIC Investment Corp (MTG) over the past 5 years. The most-recent trade in MGIC Investment Corp is the sale of 8,200,245 shares on September 16, 2009, which brought Eastbourne Capital Management Llc/ca around $74 Million.

According to the SEC Form 4 filings, Eastbourne Capital Management Llc/ca has made a total of 0 transactions in Sarepta Therapeutics Inc (SRPT) over the past 5 years. The most-recent trade in Sarepta Therapeutics Inc is the sale of 682,442 shares on March 4, 2010, which brought Eastbourne Capital Management Llc/ca around $5 Million.

According to the SEC Form 4 filings, Eastbourne Capital Management Llc/ca has made a total of 0 transactions in Cassava Sciences Inc (SAVA) over the past 5 years. The most-recent trade in Cassava Sciences Inc is the sale of 439,559 shares on September 29, 2009, which brought Eastbourne Capital Management Llc/ca around $15 Million.

More details on Eastbourne Capital Management Llc/ca's insider transactions can be found in the Insider Trading History of Eastbourne Capital Management Llc/ca table.

Insider Trading History of Eastbourne Capital Management Llc/ca

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Eastbourne Capital Management Llc/ca Trading Performance

GuruFocus tracks the stock performance after each of Eastbourne Capital Management Llc/ca's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Eastbourne Capital Management Llc/ca is 68.05%. GuruFocus also compares Eastbourne Capital Management Llc/ca's trading performance to market benchmark return within the same time period. The performance of stocks bought by Eastbourne Capital Management Llc/ca within 3 months outperforms 8 times out of 10 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Eastbourne Capital Management Llc/ca's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Eastbourne Capital Management Llc/ca

Average Return

Average return per transaction

Outperforming Transactions

9 out of 10 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	8.71
Relative Return to S&P 500(%)	14.59

Eastbourne Capital Management Llc/ca Ownership Network

Ownership Network List of Eastbourne Capital Management Llc/ca

No Data

Ownership Network Relation of Eastbourne Capital Management Llc/ca

Eastbourne Capital Management Llc/ca Owned Company Details

What does MabVax Therapeutics Holdings Inc do?

Who are the key executives at MabVax Therapeutics Holdings Inc?

Eastbourne Capital Management Llc/ca is the 10 percent owner of MabVax Therapeutics Holdings Inc. Other key executives at MabVax Therapeutics Holdings Inc include CHIEF FINANCIAL OFFICER & SECR Gregory P Hanson , EXEC. VP & R AND D Paul W Maffuid , and 10 percent owner David S Wetherell .

MabVax Therapeutics Holdings Inc (MBVXQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of MabVax Therapeutics Holdings Inc (MBVXQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of MabVax Therapeutics Holdings Inc (MBVXQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

MabVax Therapeutics Holdings Inc (MBVXQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

MabVax Therapeutics Holdings Inc Insider Transactions

No Available Data

What does Sarepta Therapeutics Inc do?

Who are the key executives at Sarepta Therapeutics Inc?

Eastbourne Capital Management Llc/ca is the 10 percent owner of Sarepta Therapeutics Inc. Other key executives at Sarepta Therapeutics Inc include Chief Financial Officer Ian Michael Estepan , Chief Tech Ops Officer Bilal Arif , and SVP & General Counsel Ryan Edward Brown .

Sarepta Therapeutics Inc (SRPT) Insider Trades Summary

Over the past 18 months, Eastbourne Capital Management Llc/ca made no insider transaction in Sarepta Therapeutics Inc (SRPT). Other recent insider transactions involving Sarepta Therapeutics Inc (SRPT) include a net purchase of 105,570 shares made by Michael Andrew Chambers , a net sale of 40,957 shares made by Ryan Edward Brown , and a net sale of 30,000 shares made by Wigzell Hans Lennart Rudolf .

In summary, during the past 3 months, insiders sold 56,699 shares of Sarepta Therapeutics Inc (SRPT) in total and bought 37,038 shares, with a net sale of 19,661 shares. During the past 18 months, 99,430 shares of Sarepta Therapeutics Inc (SRPT) were sold and 180,795 shares were bought by its insiders, resulting in a net purchase of 81,365 shares.

Sarepta Therapeutics Inc (SRPT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Sarepta Therapeutics Inc Insider Transactions

No Available Data

What does Cassava Sciences Inc do?

Who are the key executives at Cassava Sciences Inc?

Eastbourne Capital Management Llc/ca is the 10 percent owner of Cassava Sciences Inc. Other key executives at Cassava Sciences Inc include SVP & General Counsel Robert Christopher Cook , Chief Clinical Dev. Officer James William Kupiec , and Chief Financial Officer Eric Schoen .

Cassava Sciences Inc (SAVA) Insider Trades Summary

Over the past 18 months, Eastbourne Capital Management Llc/ca made no insider transaction in Cassava Sciences Inc (SAVA). Other recent insider transactions involving Cassava Sciences Inc (SAVA) include a net purchase of 30,000 shares made by Sanford Robertson , and a net purchase of 18,477 shares made by Richard Barry .

In summary, during the past 3 months, insiders sold 0 shares of Cassava Sciences Inc (SAVA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cassava Sciences Inc (SAVA) were sold and 48,477 shares were bought by its insiders, resulting in a net purchase of 48,477 shares.

Cassava Sciences Inc (SAVA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Cassava Sciences Inc Insider Transactions

No Available Data

What does MGIC Investment Corp do?

Who are the key executives at MGIC Investment Corp?

Eastbourne Capital Management Llc/ca is the 10 percent owner of MGIC Investment Corp. Other key executives at MGIC Investment Corp include SVP-Sales & Bus. Development James J. Hughes , VP-Controller & Chief Acct Off Julie K. Sperber , and Executive Vice President Patrick Sinks .

MGIC Investment Corp (MTG) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of MGIC Investment Corp (MTG) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of MGIC Investment Corp (MTG) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

MGIC Investment Corp (MTG)'s detailed insider trading history can be found in Insider Trading Tracker table.

MGIC Investment Corp Insider Transactions

No Available Data

Eastbourne Capital Management Llc/ca Mailing Address

Above is the net worth, insider trading, and ownership report for Eastbourne Capital Management Llc/ca. You might contact Eastbourne Capital Management Llc/ca via mailing address: 1101 Fifth Avenue, Suite 370, San Rafael Ca 94901.

Discussions on Eastbourne Capital Management Llc/ca

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.